)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
The acquisition adds to a series of high-value transactions at DLF's super-luxury Gurugram project, where prices have risen sharply since launch
The state regulator has directed hospitals and doctors to provide prescriptions directly to patients and allow them to buy medicines from any licensed pharmacy
The company has launched a generic version of Pfizer's Bosulif for chronic myeloid leukaemia and secured 180 days of exclusivity for the 400 mg strength
NPPA raises ceiling prices of key cancer drugs and select vaccines to address supply shortages and ensure continued availability of essential medicines
Developers brace for up to year-long project delays as the prolonged West Asia conflict raises costs, disrupts supplies and worsens labour shortages
Housing demand remains resilient and project financing is better than in previous cycles, says Anarock
Clears way for higher rates for Cisplatin and Carboplatin amid supply crunch
Vietnamese mobility firm expands workspace footprint as it scales its all-electric taxi service, with plans to add more facilities across the Delhi-NCR region
Drugmaker plans to submit orforglipron to USFDA for Type 2 diabetes approval by end of second quarter
Group launches full-stack smart co-working platform and plans to add 30-35 centres across 10 cities, targeting 50,000 seats nationwide
India's pharma sector remains resilient despite West Asia disruptions, as the government advances biopharma, R&D and bulk drug manufacturing initiatives
India plans a new support scheme for bulk drugs focused on R&D and capacity creation, while ruling out a broad medicine price hike despite rising input costs
The lease includes a 15 per cent rent escalation every three years, the documents registered in April 2026 showed
Southern states largely see stable or marginally higher fertility levels, while northern and northeastern states record declines, indicating demographic convergence
Regulator seeks state-wise enforcement data as EU, US and Japan reject consignments linked to over 40 farms
The drug regulator has asked central and state authorities to verify compliance with pharmacovigilance requirements during routine inspections and regulatory reviews
CDSCO's move can lead to the formalisation of more than 35,000 skin clinics, stop the mushrooming of single-operator setups run by unqualified practitioners
Realty developer Anant Raj has signed an MoU with the Haryana government to invest Rs 20,000 crore in data centre infrastructure and create about 6,000 jobs
There's demand for the Worldmark brand in major markets across India: CEO Sayal
According to transaction documents accessed by Propstack, the lease commenced on October 1, 2025, at a rental rate of ₹132.5 per square foot per month